Multi-country non-interventional study on the effectiveness and safety of Empagliflozin in adult patients with type 2 diabetes in Europe and Asia

21/01/2019
02/04/2024
EU PAS number:
EUPAS27606
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

The Swedish prescribed drug register, SIDIAP, NorPD, CPRD

Data sources (types)

Administrative healthcare records (e.g., claims)
Disease registry
Drug dispensing/prescription data
Electronic healthcare records (EHR)
Other

Data sources (types), other

Prospective patient-based data collection
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No